Wave Life Sciences WVE Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$183.59M— | -$204.38M— | —— | —— | —— | ||
| $3.41M-8.7% | $3.44M-11.7% | $3.5M-13.9% | $3.6M-16.8% | $3.73M-19.1% | ||
| $29.08M+91.2% | $24.97M+90.0% | $20.87M+70.3% | $17.92M+62.9% | $15.21M+53.3% | ||
| $0— | -$146K— | —— | —— | —— | ||
| —— | —— | —— | —— | $2.44M— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | -$552K— | $1.91M— | $1.71M— | ||
| —— | —— | —— | -$98.58M— | -$97.9M— | ||
| —— | —— | -$3.92M-228% | -$5.45M-274% | -$3.08M— | ||
| -$184.01M-1.9% | -$187.49M-24.1% | -$197.37M-40.4% | -$199.18M— | -$180.63M— | ||
| $992K+44.6% | $719K-23.3% | $805K-33.4% | $940K-8.1% | $686K-34.2% | ||
| -$992K-44.6% | -$719K+23.3% | -$805K+33.4% | -$940K+8.1% | -$686K+34.2% | ||
| $14.35M— | $14.87M— | —— | —— | —— | ||
| $486.61M+99.8% | $488.24M+92.3% | $83.52M-73.3% | $254.58M+130% | $243.54M+117% | ||
| —— | —— | —— | —— | —— | ||
| $301.56M+324% | $300.04M+171% | -$105.82M-162% | $63.43M— | $71.07M— | ||
| $29.08M+91.2% | $24.97M+90.0% | $20.87M+70.3% | $17.92M+62.9% | $15.21M+53.3% | ||
| $5.59M+13.5% | $5.41M+13.5% | $5.24M+13.5% | $5.08M+13.5% | $4.92M+13.5% | ||
| $3.41M-8.7% | $3.44M-11.7% | $3.5M-13.9% | $3.6M-16.8% | $3.73M-19.1% | ||
| —— | —— | —— | —— | —— | ||
| -$7.88M-13.7% | -$7.64M-13.8% | -$7.4M-13.9% | -$7.16M-14.0% | -$6.94M-14.1% | ||
| —— | —— | -$552K— | $1.91M— | $1.71M— | ||
| —— | —— | -$3.92M-228% | -$5.45M-274% | -$3.08M— | ||
| $93.37M— | $94.64M— | $47.66M— | $32.19M— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | -$98.58M— | -$97.9M— | ||
| -$185M-2.0% | -$188.21M-23.9% | -$198.17M-39.7% | -$200.12M— | -$181.32M— | ||
| -$185M-2.0% | -$188.21M-23.9% | -$198.17M-39.7% | -$200.12M— | -$181.32M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Wave Life Sciences generate?
- Wave Life Sciences (WVE) generated -$184.0M in operating cash flow over the trailing twelve months.
- What is Wave Life Sciences's free cash flow?
- After $992.0K of capital expenditures, Wave Life Sciences's free cash flow was -$185.0M over the trailing twelve months, down 2.0% year over year.
- Where does Wave Life Sciences's cash flow data come from?
- Every line is extracted from Wave Life Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
